Form 6-K Legend Biotech Corp For: Sep 14

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

Date of Report: September 14, 2026

 

Commission File Number: 001-39307

 

Legend Biotech Corporation

(Exact Name of Registrant as Specified in its Charter)

 

 

77 Corporate Drive

Bridgewater, New Jersey 08807

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F  ☒            Form 40-F  ☐

 

 

 

 

Legend Biotech Updates Clinical Pipeline

 

On September 14, 2026, Legend Biotech Corporation (the “Company”) made an updated clinical pipeline available on its website, as set forth in Exhibit 99.1 to this Form 6-K.

 

This report on Form 6-K, including the exhibits attached hereto, shall be deemed to be incorporated by reference in the registration statements of the Company on Form F-3 (Nos. 333-278050 and 333-257625) and Form S-8 (Nos. 333-239478 and 333-283217), to the extent not superseded by documents or reports subsequently filed.

 

 

EXHIBIT INDEX

 

 

Exhibit		Title
99.1		Pipeline

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

		LEGEND BIOTECH CORPORATION (Registrant)
September 14, 2026		By:		/s/ Alan Bash
				Alan Bash
				Interim Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Legend Biotech names Ingrid Zhang as new CEO, effective Sept. 15
• Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
• Best Crypto Presale 2026 Heats Up as Korean Fund Commits $30M to XRP-Focused Evernorth and Remittix Builds Toward Launch